IDIBELL (Institut d'investigació biomédica de Bellvitge)http://www.idibell.cat/es-caIDIBELLJornada de presentació del Centre de Medicina Regenerativa de Barcelona (CMR[B]) ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/580/jornada-de-presentacio-del-centre-de-medicina-regenerativa-de-barcelona-cmrb2018-01-18Lindibell, recerca amb swing! ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/579/lindibell-recerca-amb-swing2018-01-17Christopher Mueller: From embryo to adult: new insights into the function of RANKL in immunity ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/578/christopher-mueller-from-embryo-to-adult-new-insights-into-the-function-of-rankl-in-immunity2018-01-17Astrid Müller: New perspectives in behavioral addictions ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/575/astrid-muller-new-perspectives-in-behavioral-addictions2018-01-03Marc Suñé Pou: Cationic solid lipid nanoparticles (SLNs): promising drug delivery systems ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/574/marc-sune-pou-cationic-solid-lipid-nanoparticles-slns-promising-drug-delivery-systems2018-01-03[Research in Progress] N.Simonet:SirT7 is an auto-ADP-ribosyltransferase that regulates Polycomb function upon stress through histone var. macroH2A1.1 ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/573/research-in-progress-nsimonetsirt7-is-an-auto-adp-ribosyltransferase-that-regulates-polycomb-function-upon-stress-through-histone-var-macroh2a112018-01-03[Research in Progress] Iratxe Zuazo: Anti-tumor effects of Semaphorin 4D blockade unravel a novel pro-invasive mechanism of vascular targeting agents ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/572/research-in-progress-iratxe-zuazo-anti-tumor-effects-of-semaphorin-4d-blockade-unravel-a-novel-pro-invasive-mechanism-of-vascular-targeting-agents2018-01-17[Research in Progress] C. Tebé: The association between type 2 diabetes mellitus, hip fracture, and post-hip-fracture mortality: a multi-state cohort ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/571/research-in-progress-c-tebe-the-association-between-type-2-diabetes-mellitus-hip-fracture-and-post-hip-fracture-mortality-a-multi-state-cohort2018-01-03[Research in Progress] Cristina Oliveira Mateos: Epigenetic regulation mediated by antisense non-coding RNAs and its impact on oncogenic pathways ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/570/research-in-progress-cristina-oliveira-mateos-epigenetic-regulation-mediated-by-antisense-non-coding-rnas-and-its-impact-on-oncogenic-pathways2018-01-03Lliurament dels premis del comitè de recerca a la millor publicació científica i a la millor tesi doctoral del 2016 ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/569/lliurament-dels-premis-del-comite-de-recerca-a-la-millor-publicacio-cientifica-i-a-la-millor-tesi-doctoral-del-20162017-12-18Informe del director ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/568/informe-del-director2017-11-24Off-program seminar. Eva Rodriguez Aznar: Signaling pathways at the crossroad between survival, proliferation and differentiation ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/567/off-program-seminar-eva-rodriguez-aznar-signaling-pathways-at-the-crossroad-between-survival-proliferation-and-differentiation2017-11-23CMR[B] Lecture Series. Maria Carolina Florian: “Aging of hematopoietic stem cells and the epigenetic drift: a pathway to rejuvenation” ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/566/cmrb-lecture-series-maria-carolina-florian-aging-of-hematopoietic-stem-cells-and-the-epigenetic-drift-a-pathway-to-rejuvenation2017-11-23Recerca i Salut, som a prop teu: Diabetis ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/565/recerca-i-salut-som-a-prop-teu-diabetis2017-11-20Amino Acid Transport defects ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/564/amino-acid-transport-defects2017-11-13INTRODUCING CMR[B]: An official presentation for IDIBELL researchers ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/563/introducing-cmrb-an-official-presentation-for-idibell-researchers2017-11-13Álvaro Martínez del Pozo: The metamorphosis driving a water-soluble protein into the membrane

El divendres 17 de novembre de 2017 a les 13h tindrà lloc el seminari “The metamorphosis driving a water-soluble protein into the membrane” a càrrec de Álvaro Martínez del Pozo, PhD (Departamento de Bioquímica y Biología Molecular, UCM). Convidat pel Dr. Carles Solsona i Dr. Joan Blasi.

]]>
http://www.idibell.cat/modul/actes-i-sessions/ca/562/lvaro-martinez-del-pozo-the-metamorphosis-driving-a-water-soluble-protein-into-the-membrane2017-11-13
Festa MOVEMBER al Debut! ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/561/festa-movember-al-debut2017-10-27[Research in Progress] Adrià Bernat Peguera: Targeting EGFR as a therapy for human skin SCC ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/560/research-in-progress-adria-bernat-peguera-targeting-egfr-as-a-therapy-for-human-skin-scc2017-11-23[Research in Progress] Guillermo Yoldi: RANK signaling: an important player in the tumor and immune system crosstalk ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/559/research-in-progress-guillermo-yoldi-rank-signaling-an-important-player-in-the-tumor-and-immune-system-crosstalk2017-10-18Open Access Week at IDIBELL: iMarina presentation & workshops ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/558/open-access-week-at-idibell-imarina-presentation-workshops2017-10-18Xavier Trepat: Tumour invasion by stromal forces ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/557/xavier-trepat-tumour-invasion-by-stromal-forces2017-10-16Ángel Guerrero: Genomic profiling of ER-positive breast cancer after neoadjuvant endocrine therapy ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/556/ngel-guerrero-genomic-profiling-of-er-positive-breast-cancer-after-neoadjuvant-endocrine-therapy2017-10-04Luis Arnes: Positionally-conserved lncRNAs are necessary for the terminal differentiation of pancreatic lineages in development and disease ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/555/luis-arnes-positionally-conserved-lncrnas-are-necessary-for-the-terminal-differentiation-of-pancreatic-lineages-in-development-and-disease2017-09-28TERTULIAS ONCOLÓGICAS DEL CONGRESO EUROPEO ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/554/tertulias-oncolgicas-del-congreso-europeo2017-09-26[Thesis] Miguel Ángel Santos: Clinicopathologic correlations and neuroimaging biomarkers in primary progressive aphasia ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/553/thesis-miguel-ngel-santos-clinicopathologic-correlations-and-neuroimaging-biomarkers-in-primary-progressive-aphasia2017-09-26[PhD] Joanna Sierpowska:Functional mapping of language pathways in the brain: a combined intraoperative electrical stimulation & neuroimaging approach ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/552/phd-joanna-sierpowskafunctional-mapping-of-language-pathways-in-the-brain-a-combined-intraoperative-electrical-stimulation-neuroimaging-approach2017-09-22Steven Katz: Germline genetic testing and counseling after diagnosis of breast cancer

Seminar hosted by Victor Moreno, PhD

]]>
http://www.idibell.cat/modul/actes-i-sessions/ca/551/steven-katz-germline-genetic-testing-and-counseling-after-diagnosis-of-breast-cancer2017-09-21
[THESIS] Abduljalil Farwati: “Potencial diagnóstico de los miRNAs en patología inflamatoria vascular (preeclampsia e ictus)” ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/550/thesis-abduljalil-farwati-potencial-diagnostico-de-los-mirnas-en-patologia-inflamatoria-vascular-preeclampsia-e-ictus2017-09-20Francesc Garcia Gonzalo: Ciliary Functions of Phosphoinositides

El divendres 15 de desembre de 2017 a les 13h, a Sala Pau Viladiu de l'ICO (Hospital Duran i Reynals) tindrà lloc el seminari “Ciliary Functions of Phosphoinositides” a càrrec de Francesc Garcia Gonzalo, PhD (Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM) & Departamento de Bioquímica, Universidad Autónoma de Madrid &

Instituto de Investigación del Hospital Universitario de La Paz (IdiPAZ)). Convidat per José Luis Rosa, PhD.

]]>
http://www.idibell.cat/modul/actes-i-sessions/ca/549/francesc-garcia-gonzalo-ciliary-functions-of-phosphoinositides2017-10-31
Debat en dessensibilització a quimioteràpics ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/548/debat-en-dessensibilitzacio-a-quimioterapics2017-09-19Synaptic metabolism and brain circuitries in IEM ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/547/synaptic-metabolism-and-brain-circuitries-in-iem2017-09-14[Thesis] Ferran Riaño Canalias: The effect of inhibition of nucleotide synthesis on ribosome biogenesis and the induction of p53 ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/546/thesis-ferran-riano-canalias-the-effect-of-inhibition-of-nucleotide-synthesis-on-ribosome-biogenesis-and-the-induction-of-p532017-09-14[Thesis] Carmen Morcelle: The role of the RPL5/RPL11/5S rRNA complex in mediating p53 levels in response to c-Myc depletion in colorectal carcinoma ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/545/thesis-carmen-morcelle-the-role-of-the-rpl5rpl115s-rrna-complex-in-mediating-p53-levels-in-response-to-c-myc-depletion-in-colorectal-carcinoma2017-09-14[Research in Progress] Humberto Ferreira: Epigenetic regulation of non-coding regions in cancer ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/544/research-in-progress-humberto-ferreira-epigenetic-regulation-of-non-coding-regions-in-cancer2017-09-14[Thesis] Silvia García Monclús: EPHA2 com a diana terapèutica pel sarcoma d'Ewing ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/543/thesis-silvia-garcia-monclus-epha2-com-a-diana-terapeutica-pel-sarcoma-dewing2017-09-06[Research in Progress] Francisco David Morón: c-Myc effects in translation: mTORC1 signaling, protein synthesis and ribosome biogenesis ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/542/research-in-progress-francisco-david-moron-c-myc-effects-in-translation-mtorc1-signaling-protein-synthesis-and-ribosome-biogenesis2017-09-05[Research in Progress] Santiago Rello: BH3-mimetics as reinforcers of Dinaciclib therapy for Soft-tissues sarcoma ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/541/research-in-progress-santiago-rello-bh3-mimetics-as-reinforcers-of-dinaciclib-therapy-for-soft-tissues-sarcoma2017-09-05[Research in Progress] Santiago Rello: BH3-mimetics as reinforcers of Dinaciclib therapy for Soft-tissues sarcoma ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/541/research-in-progress-santiago-rello-bh3-mimetics-as-reinforcers-of-dinaciclib-therapy-for-soft-tissues-sarcoma2017-09-05[Research in Progress] Ananda Marina Rodilla: Anticancer effects of novel anion transporter molecules in lung cancer ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/540/research-in-progress-ananda-marina-rodilla-anticancer-effects-of-novel-anion-transporter-molecules-in-lung-cancer2017-09-05[Research in Progress] Olga Almacellas: Insights into the oncogenic role of lysyl oxidase-like 2 in rhabdomyosarcoma ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/539/research-in-progress-olga-almacellas-insights-into-the-oncogenic-role-of-lysyl-oxidase-like-2-in-rhabdomyosarcoma2017-09-05[Research in Progress] Olga Almacellas: Insights into the oncogenic role of lysyl oxidase-like 2 in rhabdomyosarcoma ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/539/research-in-progress-olga-almacellas-insights-into-the-oncogenic-role-of-lysyl-oxidase-like-2-in-rhabdomyosarcoma2017-09-05[Research in Progress] Montserrat Pérez: Bromodomain inhibition shows antitumoral activity in mice and human luminal breast cancer ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/538/research-in-progress-montserrat-perez-bromodomain-inhibition-shows-antitumoral-activity-in-mice-and-human-luminal-breast-cancer2017-09-05[Research in Progress] Montserrat Pérez: Bromodomain inhibition shows antitumoral activity in mice and human luminal breast cancer ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/538/research-in-progress-montserrat-perez-bromodomain-inhibition-shows-antitumoral-activity-in-mice-and-human-luminal-breast-cancer2017-09-05[Research in Progress] Montserrat Pérez: Bromodomain inhibition shows antitumoral activity in mice and human luminal breast cancer ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/538/research-in-progress-montserrat-perez-bromodomain-inhibition-shows-antitumoral-activity-in-mice-and-human-luminal-breast-cancer2017-09-05[Research in Progress] Montserrat Pérez: Bromodomain inhibition shows antitumoral activity in mice and human luminal breast cancer ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/538/research-in-progress-montserrat-perez-bromodomain-inhibition-shows-antitumoral-activity-in-mice-and-human-luminal-breast-cancer2017-09-05[Research in Progress] María Henar Alonso: Implementación de metodología estadística en la detección del mosaicismo genético ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/537/research-in-progress-maria-henar-alonso-implementacion-de-metodologia-estadistica-en-la-deteccion-del-mosaicismo-genetico2017-09-05[Research in Progress] María Henar Alonso: Implementación de metodología estadística en la detección del mosaicismo genético ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/537/research-in-progress-maria-henar-alonso-implementacion-de-metodologia-estadistica-en-la-deteccion-del-mosaicismo-genetico2017-09-05[Research in Progress] María Henar Alonso: Implementación de metodología estadística en la detección del mosaicismo genético ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/537/research-in-progress-maria-henar-alonso-implementacion-de-metodologia-estadistica-en-la-deteccion-del-mosaicismo-genetico2017-09-05[Research in Progress] María Henar Alonso: Implementación de metodología estadística en la detección del mosaicismo genético ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/537/research-in-progress-maria-henar-alonso-implementacion-de-metodologia-estadistica-en-la-deteccion-del-mosaicismo-genetico2017-09-05[Research in Progress] María Henar Alonso: Implementación de metodología estadística en la detección del mosaicismo genético ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/537/research-in-progress-maria-henar-alonso-implementacion-de-metodologia-estadistica-en-la-deteccion-del-mosaicismo-genetico2017-09-05[Research in Progress] Valentín Navarro: Inferencia Bayesiana vs frecuentista vs decisión: un punto de vista crítico sobre p-valores ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/535/research-in-progress-valentin-navarro-inferencia-bayesiana-vs-frecuentista-vs-decision-un-punto-de-vista-critico-sobre-p-valores2017-09-05Ana M. Plana: Nature and role of immune cells in the brain after stroke ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/534/ana-m-plana-nature-and-role-of-immune-cells-in-the-brain-after-stroke2017-10-02[Research in Progress] Roser E. Pons-Cusarch: Mechanisms of malignization after anti-VEGF therapies in Renal Cell Carcinoma ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/533/research-in-progress-roser-e-pons-cusarch-mechanisms-of-malignization-after-anti-vegf-therapies-in-renal-cell-carcinoma2017-09-05[PhD] Mayelín Domínguez González: Daño oxidativo y regulación redox en el envejecimiento cerebral: vulnerabilidad regional ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/532/phd-mayelin-dominguez-gonzalez-dano-oxidativo-y-regulacion-redox-en-el-envejecimiento-cerebral-vulnerabilidad-regional2017-09-01David J. Kwiatkowski: Genetic and epigenetic dissection of angiomyolipoma and lymphangioleiomyomatosis - understanding mechanism

El dimarts 12 de setembre de 2017 a les 8h, a Sala Pau Viladiu de l'ICO (Hospital Duran i Reynals) tindrà lloc el seminari “Genetic and epigenetic dissection of angiomyolipoma and lymphangioleiomyomatosis - understanding mechanism” a càrrec de David J. Kwiatkowski, MD PhD (Medical Oncologist, Thoracic Oncology Program, Dana-Farber Cancer Institute Institute. Harvard Medical School). Convidat per Miquel Àngel Pujana, PhD.

 

]]>
http://www.idibell.cat/modul/actes-i-sessions/ca/531/david-j-kwiatkowski-genetic-and-epigenetic-dissection-of-angiomyolipoma-and-lymphangioleiomyomatosis-understanding-mechanism2017-09-01
Jeff Rual: The tumor suppressor L3MBTL3 is a novel modulator of Notch signaling

El divendres 29 de setembre de 2017 a les 13h, a Sala Pau Viladiu de l'ICO (Hospital Duran i Reynals) tindrà lloc el seminari “The tumor suppressor L3MBTL3 is a novel modulator of Notch signaling” a càrrec de Jeff Rual, PhD (Universitat de Michigan). Convidat per Julián Cerón, PhD.

]]>
http://www.idibell.cat/modul/actes-i-sessions/ca/530/jeff-rual-the-tumor-suppressor-l3mbtl3-is-a-novel-modulator-of-notch-signaling2017-09-01
Sinisa Volarevic: The interplay between impaired ribosome biogenesis and p53

El dijous 28 de setembre de 2017 a les 13h, a Sala Pau Viladiu de l'ICO (Hospital Duran i Reynals) tindrà lloc el seminari The interplay between impaired ribosome biogenesis and p53” a càrrec de Sinisa Volarevic, PhD (Department de Medicina Molecular i Biotecnologia, Facultat de Medicina, Universitat de Rijeka). Convidat per Sara Kozma, PhD.

]]>
http://www.idibell.cat/modul/actes-i-sessions/ca/528/sinisa-volarevic-the-interplay-between-impaired-ribosome-biogenesis-and-p532017-09-01
Acte entrega donació Club Land Rover ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/527/acte-entrega-donacio-club-land-rover2017-07-25EATRIS Translational Medicine Conference 2017: enhancing predictivity ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/526/eatris-translational-medicine-conference-2017-enhancing-predictivity2017-07-19H2020: Oportunitats en H2020 SC1 2018-20 ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/525/h2020-oportunitats-en-h2020-sc1-2018-202017-09-18Curs de reumatologia per a residents ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/524/curs-de-reumatologia-per-a-residents2017-07-04NeuroSpring 2017 - A journey through Parkinson’s disease ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/523/neurospring-2017-a-journey-through-parkinsons-disease2017-06-07IDIBELL Seminars. Marta Valle: Applications of Population Pharmacokinetic Modeling and Simulation ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/522/idibell-seminars-marta-valle-applications-of-population-pharmacokinetic-modeling-and-simulation2017-04-28EUROPEAN RESEARCH COUNCIL (ERC) - 10 anys de recerca d'excel·lència ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/521/european-research-council-erc-10-anys-de-recerca-dexcellencia2017-04-21CMR[B] Lecture Series. Liangxue Lai: Genetically modified pig models for biomedicine ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/520/cmrb-lecture-series-liangxue-lai-genetically-modified-pig-models-for-biomedicine2017-04-18B·Debate: Women's Cancer: Personal and Scientific Challenges ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/519/bdebate-womens-cancer-personal-and-scientific-challenges2017-04-11Controversias en esclerosis múltiple ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/518/controversias-en-esclerosis-multiple2017-05-26IDIBELL Seminars - Cancer Series. Pere Roca-Cusachs:''Sensing matrix rigidity: transducing mechanical signals from integrins to the nucleus'' ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/517/idibell-seminars-cancer-series-pere-roca-cusachssensing-matrix-rigidity-transducing-mechanical-signals-from-integrins-to-the-nucleus2017-03-28II IDIBELL PhD day ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/516/ii-idibell-phd-day2017-03-20IDIBELL Seminars. Marc Bonten: What does antibiotic resistance mean for our patients? The Netherlands vs Spain ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/515/idibell-seminars-marc-bonten-what-does-antibiotic-resistance-mean-for-our-patients-the-netherlands-vs-spain2017-03-20Lectura de tesi. Ana Angulo: Regulation of actomyosin contractility by p110α PI3-kinase in sprouting angiogenesis ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/514/lectura-de-tesi-ana-angulo-regulation-of-actomyosin-contractility-by-p110-945-pi3-kinase-in-sprouting-angiogenesis2017-02-17Zumba solidària - investiguem en síndrome de Rett ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/513/zumba-solidaria-investiguem-en-sindrome-de-rett2017-02-15Lectura de tesi. Gemma Binefa: Avaluació de la qualitat del Programa de cribratge de càncer colorectal de l’Hospitalet de Llobregat ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/512/lectura-de-tesi-gemma-binefa-avaluacio-de-la-qualitat-del-programa-de-cribratge-de-cancer-colorectal-de-lhospitalet-de-llobregat2017-02-14Dia Mundial de les Malalties Rares ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/511/dia-mundial-de-les-malalties-rares2017-02-13IDIBELL Seminars. Isabel Ruiz: Prevention of infection in patients with biological therapies: Is there a higher risk of infection? ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/510/idibell-seminars-isabel-ruiz-prevention-of-infection-in-patients-with-biological-therapies-is-there-a-higher-risk-of-infection2017-02-13IDIBELL Seminars. Juan Ramón González: Transcriptomic and epigenomic changes induced by the exposome and its association with chronic diseases ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/509/idibell-seminars-juan-ramon-gonzalez-transcriptomic-and-epigenomic-changes-induced-by-the-exposome-and-its-association-with-chronic-diseases2017-02-06IDIBELL Seminars. Rafael Luján: Subcellular organization of receptors and ion channels along the neuronal surface in normal and pathological condition ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/508/idibell-seminars-rafael-lujan-subcellular-organization-of-receptors-and-ion-channels-along-the-neuronal-surface-in-normal-and-pathological-condition2017-02-06Taula rodona ''Dones i Ciència: passat, present i futur''

El proper 11 de febrer és el Dia Internacional de la dona i la nena en la ciència. Es tracta d’una data escollida per les Nacions Unides amb la idea de promoure les perspectives de carrera de les dones en la ciència i de reconèixer els seus èxits en aquests camp

]]>
http://www.idibell.cat/modul/actes-i-sessions/ca/507/taula-rodona-dones-i-ciencia-passat-present-i-futur2017-02-03
Formació en Innovació: Les Spin-off ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/506/formacio-en-innovacio-les-spin-off2017-01-30Jornada “LA TECNOLOGIA AL SERVEI DE LA SALUT I LA RECERCA MÈDICA'' ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/505/jornada-la-tecnologia-al-servei-de-la-salut-i-la-recerca-mdica2017-01-30Dia Mundial del Càncer ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/504/dia-mundial-del-cancer2017-01-30IDIBELL Seminars. Khalid Fakhro: Building a genomics enterprise in the desert: Towards personalized medicine in Qatar ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/503/idibell-seminars-khalid-fakhro-building-a-genomics-enterprise-in-the-desert-towards-personalized-medicine-in-qatar2017-01-30Extraordinary Seminar. Joaquín Dopazo: Prognostic cancer biomarkers derived from models of pathway activity ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/502/extraordinary-seminar-joaquin-dopazo-prognostic-cancer-biomarkers-derived-from-models-of-pathway-activity2016-12-13IDIBELL Seminars. Beatriz Domínguez-Gil: Sistema español de donación y trasplantes: ¿Cómo hemos logrado alcanzar 40 donantes por millón de población? ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/501/idibell-seminars-beatriz-dominguez-gil-sistema-espanol-de-donacion-y-trasplantes-como-hemos-logrado-alcanzar-40-donantes-por-millon-de-poblacion2016-11-14Extraordinary Seminar. Klaus Wimmer: Neural network dynamics underlying cognitive function ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/500/extraordinary-seminar-klaus-wimmer-neural-network-dynamics-underlying-cognitive-function2016-11-14IDIBELL Seminars. Jose Antonio Enríquez: Mitochondrial and nuclear DNA matching shapes metabolism and healthy ageing ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/499/idibell-seminars-jose-antonio-enriquez-mitochondrial-and-nuclear-dna-matching-shapes-metabolism-and-healthy-ageing2016-11-07Group leader Seminars. Ethel Queralt & David Monk ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/498/group-leader-seminars-ethel-queralt-david-monk2016-11-04Visita del Conseller d’Empresa i Coneixement a l’Institut d’Investigació Biomèdica de Bellvitge ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/497/visita-del-conseller-dempresa-i-coneixement-a-linstitut-dinvestigacio-biomedica-de-bellvitge2016-11-02IDIBELL Seminars. Nicolai Bovin: Natural anti-carbohydrate antibodies: Origin and potential medical applications ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/496/idibell-seminars-nicolai-bovin-natural-anti-carbohydrate-antibodies-origin-and-potential-medical-applications2016-10-28Festa #Movember al Debut ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/495/festa-movember-al-debut2016-10-27IDIBELL Seminars. Miguel Ángel Alonso: Función de la proteína MAL en el tráfico de membranas de células epiteliales y linfocitos T ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/494/idibell-seminars-miguel-ngel-alonso-funcion-de-la-proteina-mal-en-el-trafico-de-membranas-de-celulas-epiteliales-y-linfocitos-t2016-11-28Special seminar. David Curiel: Dendritic cell targeted adenoviral vaccines for cancer immunotherapy ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/493/special-seminar-david-curiel-dendritic-cell-targeted-adenoviral-vaccines-for-cancer-immunotherapy2016-10-13IDIBELL Seminars. Lluís Montoliu: New mouse models of rare diseases generated with the CRISPR/Cas system ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/492/idibell-seminars-lluis-montoliu-new-mouse-models-of-rare-diseases-generated-with-the-crisprcas-system2016-10-13IDIBELL Seminars. Thomas Graf: Mechanisms of C/EBPa induced transdifferentiation and facilitated pluripotency reprogramming ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/491/idibell-seminars-thomas-graf-mechanisms-of-cebpa-induced-transdifferentiation-and-facilitated-pluripotency-reprogramming2016-10-13IDIBELL Seminars. William Foulkes: New genes for rare tumors: the DICER1 and SMARCA4 spectrum ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/490/idibell-seminars-william-foulkes-new-genes-for-rare-tumors-the-dicer1-and-smarca4-spectrum2016-10-11IDIBELL Seminars. Toni Valero-Cabre: Direct brain stimulation: challenges and future directions ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/489/idibell-seminars-toni-valero-cabre-direct-brain-stimulation-challenges-and-future-directions2016-10-10IDIBELL Seminars. Andreu Casali: Drosophila as a model for human diseases: the case of colorectal cancer

Next September 30th, at 1 pm, the Pau Viladiu Hall of Duran i Reynals Hospital holds the seminar “Drosophila as a model for human diseases: the case of colorectal cancer“  by Andreu Casali (IRB Barcelona). Hosted by Dr. Álex Vaquero.

]]>
http://www.idibell.cat/modul/actes-i-sessions/ca/488/idibell-seminars-andreu-casali-drosophila-as-a-model-for-human-diseases-the-case-of-colorectal-cancer2016-09-26
Special seminar: Marie Arsenian Henriksson: MYCN and differentiation control in childhood neuroblastoma

Next Thursday 29th September at 1pm, the Pau Viladiu Hall of Hospital Duran i Reynals holds the seminar “MYCN and differentiation control in childhood neuroblastoma“ by Dr. Marie Arsenian Henriksson (Department of Microbiology, Tumor Biology (MTC) Karolinska Institutet, Stockholm, Sweden). Hosted by Manuel Torres Diz.

]]>
http://www.idibell.cat/modul/actes-i-sessions/ca/487/special-seminar-marie-arsenian-henriksson-mycn-and-differentiation-control-in-childhood-neuroblastoma2016-09-26
IDIBELL Seminars. Ana Janic: Identification of the critical p53 tumour suppression mechanisms in vivo ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/486/idibell-seminars-ana-janic-identification-of-the-critical-p53-tumour-suppression-mechanisms-in-vivo2016-09-16